245 related articles for article (PubMed ID: 4935767)
1. Global ratings compared to rating scales in evaluating trifluoperazine-amobarbital in anxious psychoneurotic outpatients.
Bercel NA
Behav Neuropsychiatry; 1971; 2(11):15-9. PubMed ID: 4935767
[No Abstract] [Full Text] [Related]
2. A new rating scale for evaluating clinical response in psychoneurotic outpatients.
Free SM; Guthrie MB
J Clin Pharmacol J New Drugs; 1969; 9(3):187-94. PubMed ID: 5255182
[No Abstract] [Full Text] [Related]
3. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
Guthrie MB; Free SM
Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
[No Abstract] [Full Text] [Related]
4. Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
Mendels J; Krajewski TF; Huffer V; Taylor RJ; Secunda S; Schless A; Sebastian JA; Semchyshyn G; Durr MJ; Melmed AS
J Clin Psychiatry; 1986 Apr; 47(4):170-4. PubMed ID: 3514583
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of evaluating psychopharmaceutical agents in cooperative studies in private practice.
Free SM; Rudnick A
Dis Nerv Syst; 1970 Nov; 31(11):763-6. PubMed ID: 4923152
[No Abstract] [Full Text] [Related]
6. Factor analysis of outpatient clinical data.
Free SM
J Clin Pharmacol J New Drugs; 1969; 9(3):195-9. PubMed ID: 5255183
[No Abstract] [Full Text] [Related]
7. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
Gross HS
Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
[No Abstract] [Full Text] [Related]
8. Comparison of prothiadene and chorprotixene in neurtoic inpatients.
Hausner M; Dolezal V
Act Nerv Super (Praha); 1968 Oct; 10(3):298-9. PubMed ID: 4883238
[No Abstract] [Full Text] [Related]
9. [Anxiety and hostility in psychosomatic and psychoneurotic patients: analysis of the content of verbal expression].
Lolas F; von Rad M
Acta Psiquiatr Psicol Am Lat; 1977 Sep; 23(3):184-93. PubMed ID: 602802
[No Abstract] [Full Text] [Related]
10. Trazodone in the treatment of psychoneuroses: a double-blind study.
Antonelli F; De Gregorio M; Dionisio A
Curr Ther Res Clin Exp; 1973 Oct; 15(10):799-804. PubMed ID: 4201978
[No Abstract] [Full Text] [Related]
11. A clinical comparison of molindone hydrochloride with trifluoperazine in psychotic outpatients.
Brauzer B; Goldstein BJ
Curr Ther Res Clin Exp; 1971 Mar; 13(3):152-7. PubMed ID: 4998285
[No Abstract] [Full Text] [Related]
12. Evaluating clinical improvement in anxious outpatients: a comparison of normal and treated neurotic patients.
Rickels K; Lipman RS; Garcia CR; Fisher E
Am J Psychiatry; 1972 Feb; 128(8):1005-9. PubMed ID: 4550730
[No Abstract] [Full Text] [Related]
13. Response threshold to levodopa in psychiatric patients.
Sathananthan G; Angrist BM; Gershon S
Biol Psychiatry; 1973 Oct; 7(2):139-46. PubMed ID: 4584028
[No Abstract] [Full Text] [Related]
14. Controlled comparison of trebenzomine with doxepin as an antidepressant-anxiolytic.
Pena-Ramos A; Muniz C; Goodman LI; Borgen LA
J Clin Psychiatry; 1979 Feb; 40(2):104-6. PubMed ID: 368044
[TBL] [Abstract][Full Text] [Related]
15. The anti-anxiety effects of haloperidol and trifluoperazine in an outpatient neurotic population.
Rossman M; Moskowitz M; Fleishman P; Sheppard C; Merlis S
Dis Nerv Syst; 1970 Nov; 31():Suppl:130-3. PubMed ID: 5489378
[No Abstract] [Full Text] [Related]
16. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
Claghorn JL
Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
[No Abstract] [Full Text] [Related]
17. Lormetazepam and amobarbital sodium in the outpatient treatment of insomnia: a controlled trial.
Ansseau M; Diricq S
Clin Ther; 1983; 5(4):365-76. PubMed ID: 6135507
[TBL] [Abstract][Full Text] [Related]
18. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
Khorana AB; Patel Y
Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol--new addition to the drug treatment of schizophrenia.
Stewart A; Lafave HG; Segovia G
Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
[No Abstract] [Full Text] [Related]
20. [Tranylcypromine, trifluoperazine, diazepam and amobarbital in anxiety and depressive states. Clinical experimentation].
Auletta HV; Munist L; Brelio HS; Geretto MA; De Aguilar Vde B
Prensa Med Argent; 1971 Dec; 58(37):1839-46. PubMed ID: 5136688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
